{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,6]],"date-time":"2024-03-06T11:39:39Z","timestamp":1709725179759},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2008,3,6]],"date-time":"2008-03-06T00:00:00Z","timestamp":1204761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2008,3,6]],"date-time":"2008-03-06T00:00:00Z","timestamp":1204761600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Invest New Drugs"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1007\/s10637-008-9119-2","type":"journal-article","created":{"date-parts":[[2008,3,5]],"date-time":"2008-03-05T13:58:39Z","timestamp":1204725519000},"page":"505-516","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Modulation of key signal transduction molecules by a novel peptide combination effective for the treatment of gastrointestinal carcinomas"],"prefix":"10.1007","volume":"26","author":[{"given":"Anu T.","family":"Singh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manu","family":"Jaggi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sudhanand","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarjana","family":"Dutt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gurvinder","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kakali","family":"Datta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Praveen","family":"Rajendran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinod K.","family":"Sanna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rama","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anand C.","family":"Burman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,3,6]]},"reference":[{"key":"9119_CR1","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1210\/er.2002-0007","volume":"24","author":"JC Reubi","year":"2003","unstructured":"Reubi JC (2003) Peptide Receptors as molecular targets for cancer diagnosis and therapy. Endocr Rev 24:389\u2013427","journal-title":"Endocr Rev"},{"key":"9119_CR2","doi-asserted-by":"publisher","unstructured":"Jaggi M, Prasad S, Singh AT, Praveen R, Dutt S, Mathur A, Sharma R, Gupta N, Ahuja R, Mukherjee R, Burman AC (2008) Anticancer activity of a peptide combination in Gastrointestinal cancers targeting multiple neuropeptide receptors. Invest New Drugs. DOI 10.1007\/s10637-008-9117-4","DOI":"10.1007\/s10637-008-9117-4"},{"key":"9119_CR3","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1023\/A:1008201723418","volume":"8","author":"D Corda","year":"1997","unstructured":"Corda D, Incalci MD (1997) Cell signaling and cancer treatment. Ann Oncol 8:429\u2013433","journal-title":"Ann Oncol"},{"key":"9119_CR4","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1056\/NEJM198010093031511","volume":"303","author":"MB Sporn","year":"1980","unstructured":"Sporn MB, Todaro GJ (1980) Autocrine secretion and malignant transformation of cells. N Engl J Med 303:378\u2013389","journal-title":"N Engl J Med"},{"key":"9119_CR5","first-page":"3105","volume":"60","author":"JC Reubi","year":"2000","unstructured":"Reubi JC, Laderach U, Waser B, Gebbers JO, Robberecht P, Laissue JA (2000) Vasoactive intestinal peptide\/pituitary adenylate cyclase-activating peptide receptor subtypes in human tumours and their tissues of origin. Cancer Res 60:3105\u20133112","journal-title":"Cancer Res"},{"key":"9119_CR6","first-page":"1139","volume":"8","author":"JC Reubi","year":"2002","unstructured":"Reubi JC, Wenger S, Maurer JS, Schaer JC, Gugger M (2002) Bombesin receptor subtypes in human cancers: detection with the universal radioligand 125I-(D-Tyr6, {beta}-ALA11, PHE13, NLE14) Bombesin (6\u201314). Clin Cancer Res 8:1139\u20131146","journal-title":"Clin Cancer Res"},{"key":"9119_CR7","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1038\/nrd1255","volume":"2","author":"G Weckbecker","year":"2003","unstructured":"Weckbecker G, Lewis I, Albert R, Schmid HA, Hoyer D, Bruns C (2003) Opportunities in somatostatin research: biological, chemical and therapeutic aspects. Nat Rev Drug Discov 2:999\u20131017","journal-title":"Nat Rev Drug Discov"},{"key":"9119_CR8","first-page":"1114","volume":"52","author":"H Frucht","year":"1992","unstructured":"Frucht H, Gazdar AF, Park JA, Jensen RT (1992) Characterization of functional receptors for gastrointestinal hormones on human colon cancer cells. Cancer Res 52:1114\u20131122","journal-title":"Cancer Res"},{"key":"9119_CR9","unstructured":"Pimentel E (1994) Growth factors and neoplasia. In: Handbook of growth factors: general basic aspects, vol. 1. CRC Press, USA, pp 329\u2013337"},{"key":"9119_CR10","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1634\/theoncologist.7-suppl_4-31","volume":"7","author":"CL Arteaga","year":"2002","unstructured":"Arteaga CL (2002) Epidermal growth factor receptor dependence in human tumours: more than just expression. Oncologist 7:31\u201339","journal-title":"Oncologist"},{"key":"9119_CR11","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S0344-0338(96)80098-7","volume":"192","author":"EJ Van Zoelen","year":"1996","unstructured":"Van Zoelen EJ, Lenferink AE, Kramer RH, Van de Poll ML (1996) Rational design for the development of epidermal growth factor receptor antagonists. Pathol Res Pract 192:761\u2013767","journal-title":"Pathol Res Pract"},{"key":"9119_CR12","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/1040-8428(94)00144-I","volume":"19","author":"DS Salomon","year":"1995","unstructured":"Salomon DS, Brandt R, Ciardiello F, Normanno N (1995) Epidermal growth factor related peptides and their receptors in human malignancies. Crit Rev Oncol Hematol 19:183\u2013232","journal-title":"Crit Rev Oncol Hematol"},{"key":"9119_CR13","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1038\/sj.onc.1204183","volume":"20","author":"LE Heasley","year":"2001","unstructured":"Heasley LE (2001) Autocrine and paracrine signaling through neuropeptide receptors in human cancers. Oncogene 20:1563\u20131569","journal-title":"Oncogene"},{"key":"9119_CR14","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/35052073","volume":"2","author":"Y Yarden","year":"2001","unstructured":"Yarden Y, Sliwkowski MX (2001) Untangling the ErbB signaling network. Nat Rev Mol Cell Biol 2:127\u2013137","journal-title":"Nat Rev Mol Cell Biol"},{"key":"9119_CR15","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/S0955-0674(99)80028-3","volume":"11","author":"TP Garrington","year":"1999","unstructured":"Garrington TP, Johnson GL (1999) Organization and regulation of mitogen-activated protein kinase signaling pathways. Cur Opin Cell Biol 1999 11:211\u2013218","journal-title":"Cur Opin Cell Biol 1999"},{"key":"9119_CR16","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/bjc.1998.675","volume":"78","author":"J Ostrowski","year":"1997","unstructured":"Ostrowski J, Trzeciak L, Kolodziejski J, Bomsztyk K (1997) Increased constitutive activity of mitogen-activated protein kinase and renaturable 85\u00a0kDa kinase in human colorectal cancer. Br J Cancer 78:1301\u20131306","journal-title":"Br J Cancer"},{"key":"9119_CR17","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/284555a0","volume":"284","author":"AH Wyllie","year":"1980","unstructured":"Wyllie AH (1980) Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 284:555\u2013556","journal-title":"Nature"},{"key":"9119_CR18","first-page":"2148","volume":"56","author":"A Peled","year":"1996","unstructured":"Peled A, Zipori D, Rotter V (1996) Cooperation between p53 dependant and p53 independent apoptotic pathways in myeloid cells. Cancer Res 56:2148\u20132156","journal-title":"Cancer Res"},{"key":"9119_CR19","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1200\/JCO.1998.16.9.3158","volume":"16","author":"DG Kirsch","year":"1998","unstructured":"Kirsch DG, Kastan MB (1998) Tumour suppressor p53: implications for tumour development and prognosis. J Clin Oncol 16:3158\u20133168","journal-title":"J Clin Oncol"},{"key":"9119_CR20","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1002\/(SICI)1097-4644(19960101)60:1<23::AID-JCB5>3.0.CO;2-5","volume":"60","author":"JC Reed","year":"1996","unstructured":"Reed JC, Miyashita T, Takayama S, Wang HG, Sato T, Krajewski S, Aime-Seme C, Bodrug S, Kitada S, Hanada M (1996) Bcl-2 family proteins: regulators of cell death involved in the pathogenesis of cancer. J Cell Biochem 60:23\u201332","journal-title":"J Cell Biochem"},{"key":"9119_CR21","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/bjc.1972.33","volume":"26","author":"JF Kerr","year":"1972","unstructured":"Kerr JF, Wyllie AH, Currie AR (1972) Apoptosis: a basic phenomenon and wide ranging implications in tissue kinetics. Br J Cancer 26:239\u2013257","journal-title":"Br J Cancer"},{"key":"9119_CR22","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1146\/annurev.biochem.68.1.383","volume":"68","author":"WC Earnshaw","year":"1999","unstructured":"Earnshaw WC, Martins L, Kaufmann SH (1999) Mammalian caspases: structure, activation, substrates and functions during apoptosis. Ann Rev Biochem 68:383\u2013424","journal-title":"Ann Rev Biochem"},{"key":"9119_CR23","doi-asserted-by":"publisher","first-page":"20049","DOI":"10.1074\/jbc.274.29.20049","volume":"274","author":"BB Wolf","year":"1999","unstructured":"Wolf BB, Green DR (1999) Suicidal tendencies: apoptotic cell dearth by caspase family proteases. J Biol Chem 274:20049\u201320052","journal-title":"J Biol Chem"},{"key":"9119_CR24","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S0026-0495(96)90080-3","volume":"45","author":"R Danesi","year":"1996","unstructured":"Danesi R, Del TM (1996) The effects of the somatostatin analogue ocreotide on angiogenesis in vitro. Metabolism 45:49\u201350","journal-title":"Metabolism"},{"key":"9119_CR25","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/0022-4804(91)90186-P","volume":"50","author":"EA Woltering","year":"1991","unstructured":"Woltering EA, Barrie R, O\u2019Dorisio TM, Arce D, Ure T, Cramer A, Holmes D, Robertson J, Fassler J (1991) Somatostatin analogues inhibit angiogenesis in the chick chorioallantoic membrane. J Surg Res 50:245\u2013251","journal-title":"J Surg Res"},{"key":"9119_CR26","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.pharmthera.2004.02.002","volume":"102","author":"P Dasgupta","year":"2004","unstructured":"Dasgupta P (2004) Somatostatin analogues: multiple roles in cellular proliferation, neoplasia and angiogenesis. Pharmacol Ther 102:61\u201385","journal-title":"Pharmacol Ther"},{"key":"9119_CR27","first-page":"3495","volume":"63","author":"L Levine","year":"2003","unstructured":"Levine L, Lucci JA 3rd, Pazdrak B, Cheng JZ, Guo YS, Townsend TM, Hellmich MR (2003) Bombesin stimulates nuclear factor kB activation and expression of proangiogenic factors in prostate cancer cells. Cancer Res 63:3495\u20133502","journal-title":"Cancer Res"},{"key":"9119_CR28","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.regpep.2004.01.013","volume":"119","author":"B Collado","year":"2004","unstructured":"Collado B, Canas IG, Henche NR, Prieto JC, Carmena MJ (2004) Vasoactive intestinal peptide increases vascular endothelial growth factor expression and neuroendocrine differentiation in human prostate cancer LNCAP cells. Regulatory Pept 119:69\u201375","journal-title":"Regulatory Pept"},{"key":"9119_CR29","unstructured":"Mukherjee R, Jaggi M: Drug for treatment of cancer. US Patent 6,156,725"},{"key":"9119_CR30","unstructured":"Mukherjee R, Jaggi M, Prasad S, Burman AC, Praveen R, Mathur A, Singh AT: Antiangogenic drugs. US Patent 6,492,330"},{"key":"9119_CR31","unstructured":"Burman AC, Prasad S, Mukherjee R, Jaggi M, Singh AT, Mathur A: Somatostatin analogs for the treatment of cancer. US Patent 6,316,414"},{"key":"9119_CR32","unstructured":"Burman AC, Prasad S, Mukherjee R, Jaggi M, Singh AT, Sharma R: Peptides for the treatment of cancer. US Patent 6,828,304"},{"key":"9119_CR33","unstructured":"Burman AC, Prasad S, Mukherjee R, Jaggi M, Singh AT: Substance P analogs for the treatment of cancer. US Patent 6,596,692"},{"key":"9119_CR34","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1002\/cncr.11649","volume":"98","author":"K Szapeshazi","year":"2003","unstructured":"Szapeshazi K, Schally AV, Nagy A, Wagner BW, Bajo AM, Halmos G (2003) Preclinical evaluation of therapeutic effects of targeted cytotoxic analogs of somatostatin and bombesin on human gastric carcinomas. Cancer 98:1401\u20131410","journal-title":"Cancer"},{"key":"9119_CR35","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1002\/pros.20262","volume":"64","author":"A Stangelberger","year":"2005","unstructured":"Stangelberger A, Schally AV, Varga JL, Hammann BD, Groot K, Halmos G, Cai RZ, Zarandi M (2005) Antagonists of growth hormone releasing hormone (GHRH) and of bombesin\/gastrin releasing peptide (BN\/GRP) suppress the expression of VEGF, bFGF and receptors of the EGF\/HER family in PC-3 and DU 145 human androgen independent prostate cancers. Prostate 64:303\u2013315","journal-title":"Prostate"},{"key":"9119_CR36","doi-asserted-by":"publisher","first-page":"2738","DOI":"10.1158\/0008-5472.CAN-04-3197","volume":"65","author":"S Guha","year":"2005","unstructured":"Guha S, Eibl G, Kisfalvi K, Fan RS, Burdick M, Reber H, Hines OJ, Strieter R, Rozengurt E (2005) Broad spectrum G protein coupled receptor antagonist (d-Arg, d-Trp 5,7, 9, Leu 11) SP: a dual inhibitor of growth and angiogenesis in pancreatic cancer. Cancer Res 65:2738\u20132745","journal-title":"Cancer Res"},{"key":"9119_CR37","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/0968-0004(89)90046-7","volume":"14","author":"JE Dumont","year":"1989","unstructured":"Dumont JE, Jauniax JC, Roger PP (1989) The cAMP mediated stimulation of cell proliferation. Trends Biochem Sci 14:67\u201371","journal-title":"Trends Biochem Sci"},{"key":"9119_CR38","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/9780470514733.ch10","volume-title":"Somatostatin and its receptors, vol 162","author":"T Reisine","year":"1995","unstructured":"Reisine T, Woulfe D, Raynor K, Kong H, Heerding J, Hines J (1995) Interaction of somatostatin receptors with G-proteins and cellular effector systems. In: Chadwick DJ, Cardew G (eds) Somatostatin and its receptors, vol 162. Wiley, New York, pp 160\u2013170"},{"key":"9119_CR39","first-page":"4453","volume":"58","author":"S Fulda","year":"1998","unstructured":"Fulda S, Susin SA, Kroemer G, Debatin KM (1998) Molecular ordering of apoptosis induced by anticancer drugs in neuroblastoma cells. Cancer Res 58:4453\u20134460","journal-title":"Cancer Res"},{"key":"9119_CR40","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1002\/ijc.2910600521","volume":"60","author":"Y Qin","year":"1995","unstructured":"Qin Y, Ertl T, Groot K, Horvath J, Cai RZ, Schally AV (1995) Somatostatin analog C-160 inhibits growth of CFPAC-1 human pancreatic carcinoma cells in vitro and intracellular production of cAMP. Int J Cancer 60:694\u2013700","journal-title":"Int J Cancer"},{"key":"9119_CR41","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1002\/(SICI)1097-0215(19980413)76:2<259::AID-IJC14>3.0.CO;2-7","volume":"76","author":"K Sharma","year":"1998","unstructured":"Sharma K, Srikant CB (1998) Induction of wild-type p53, Bax, and acidic endonuclease during somatostatin-signaled apoptosis in MCF-7 human breast cancer cells. Int J Cancer 76:259\u2013266","journal-title":"Int J Cancer"},{"key":"9119_CR42","first-page":"3123","volume":"20","author":"Y Matsumoto","year":"2000","unstructured":"Matsumoto Y, Kawatani M, Simizu S, Tanaka T, Takada M, Imoto M (2000) Bcl-2-independent induction of apoptosis by neuropeptide receptor antagonist in human small cell lung carcinoma cells. Anticancer Res 20:3123\u20133129","journal-title":"Anticancer Res"},{"key":"9119_CR43","first-page":"4255","volume":"56","author":"A Tallet","year":"1996","unstructured":"Tallet A, Chilvers ER, Hannah S, Dransfield I, Lawson MF, Haslett C, Sethi T (1996) Inhibition of neuropeptide-stimulated tyrosine phosphorylation and tyrosine kinase activity stimulates apoptosis in small cell lung cancer cells. Cancer Res 56:4255\u20134263","journal-title":"Cancer Res"},{"key":"9119_CR44","unstructured":"Mukherjee R, Doval D C, Raghunadharao D, Majumdar A, Ganguly S, Jaggi M, Prasad S, Singh AT, Burman AC (2003) Phase I dose escalating study of DRF7295: A new class of peptide based drugs. \u201cAbstract\u201d ASCO ID:948"}],"container-title":["Investigational New Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-008-9119-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10637-008-9119-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-008-9119-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-008-9119-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,11]],"date-time":"2023-03-11T18:33:38Z","timestamp":1678559618000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10637-008-9119-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3,6]]},"references-count":44,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["9119"],"URL":"https:\/\/doi.org\/10.1007\/s10637-008-9119-2","relation":{},"ISSN":["0167-6997","1573-0646"],"issn-type":[{"value":"0167-6997","type":"print"},{"value":"1573-0646","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,3,6]]},"assertion":[{"value":"6 December 2007","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2008","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2008","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}